Business Context and Reporting Period
This Form 10-Q covers The Procter & Gamble Company for the quarterly period ended September 30, 2001. The company operates globally across six primary segments: Baby, Fabric & Home Care, Feminine & Family Care, Beauty Care, Health Care, and Food & Beverage. The financial statements are unaudited but include all adjustments necessary for a fair presentation.
Key Financial Metrics
| Metric | Q1 2002 (Sep 30, 2001) | Q1 2001 (Sep 30, 2000) |
|---|---|---|
| Net Sales | $9,766 million | $9,969 million |
| Operating Income | $1,762 million | $1,779 million |
| Net Earnings | $1,104 million | $1,155 million |
| Diluted EPS | $0.79 | $0.82 |
| Core Net Earnings (Adj.) | $1,342 million ($0.96/share) | $1,208 million ($0.86/share) |
| Operating Cash Flow | $1,329 million | $1,081 million |
| Cash and Equivalents (End) | $2,893 million | $2,001 million |
| Total Debt (Short + Long) | $12,645 million | Filing text does not provide clear prior year total debt |
| Gross Margin | 47.7% | 46.8% |
| Operating Margin | 18.0% | 17.8% |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 2.0% year-over-year, driven by unfavorable foreign exchange rates, divestitures, and lower unit volumes in Fabric & Home Care and Food & Beverage.
- Restructuring Charges: The quarter included a significant $310 million pre-tax ($238 million after-tax) restructuring charge related to the "Organization 2005" initiative. This included $212 million for employee separations (approx. 3,000 people) and $63 million for asset write-downs and accelerated depreciation.
- Accounting Changes: Effective July 1, 2001, the company adopted SFAS No. 142, eliminating the amortization of goodwill and indefinite-life intangible assets. This resulted in a $53 million after-tax benefit to the prior year's comparable period when adjusted.
- Segment Performance:
- Health Care: Strongest performer with 73% earnings growth and 21% sales growth, driven by oral care (Whitestrips, Spinbrush) and pharmaceuticals (Actonel).
- Beauty Care: Earnings grew 22% despite flat sales, due to marketing efficiencies and portfolio shifts.
- Fabric & Home Care: Earnings declined 10% due to lower sales and prior-year divestitures.
Guidance, Outlook, and Risks
Management Commentary: Management highlighted that core earnings (excluding restructuring and accounting adjustments) grew significantly. The company is focusing on cost savings, marketing efficiencies, and portfolio optimization. The restructuring program is expected to continue delivering cost reductions through manufacturing consolidation and overhead reduction.
Outlook: The filing notes that interim results are not necessarily indicative of annual results. Management confirmed previously issued guidance for the quarter in an August 8-K filing.
Risks and Contingencies:
- Goodwill Impairment: While management preliminarily assesses no impairment, the annual assessment required by SFAS 142 must be completed by December 31, 2001.
- Shareholder Proposals: Several shareholder resolutions regarding cumulative voting, director election terms, genetically engineered ingredients, and labor standards were defeated at the October 2001 annual meeting.
- Foreign Exchange: Continued unfavorable currency impacts negatively affected sales comparisons in multiple segments.
Investor Verification Checklist
- Restructuring Execution: Verify the progress of the "Organization 2005" program and the actual realization of the projected cost savings.
- Goodwill Assessment: Monitor the outcome of the mandatory goodwill impairment test due by December 31, 2001.
- Core Earnings Sustainability: Confirm if the growth in core earnings (excluding one-time charges) is sustainable given the decline in reported net sales.
- Debt Management: Review the net debt position, which increased slightly to fund share repurchases, and assess liquidity coverage.
- Segment Mix: Analyze the shift in revenue mix toward higher-margin segments like Health Care and Beauty Care versus volume declines in Fabric & Home Care.